| Quest – Discovery Stage Research Projects | Stanford University | iPSC-derived smooth muscle cell progenitor conditioned medium for treatment of pelvic organ prolapse |
$1,420,200 |
| Inception – Discovery Stage Research Projects | Stanford University | Autologous iPSC-based therapy for radiation induced bladder injury |
$235,836 |
| Therapeutic Translational Research Projects | Stanford University | Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence |
$5,977,155 |
| Early Translational III | Stanford University | Autologous iPSC Therapy for Urinary Incontinence |
$4,715,738 |
